Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Diseases × Surgimend × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1 Breast Diseases 1

Interventions

Letrozole 4 pyrotinib 3 palbociclib 3 Trastuzumab 3 Anastrozole 3 abemaciclib 2 Sodium Chloride 2 Exercise 2 Epirubicin 2 Docetaxel 2 Cyclophosphamide 2 Botulinum Toxins, Type A 2 sacubitril and valsartan sodium hydrate drug combination 1 ribociclib 1 pertuzumab 1 gadoterate meglumine 1 exemestane 1 Vinorelbine 1 Tomography, X-Ray Computed 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgimend 1 Surgical Procedures, Operative 1 Paclitaxel 1 Mammaplasty 1 Liquid Biopsy 1 Leflunomide 1 Lapatinib 1 High-Energy Shock Waves 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02557906 2018-03-13

POBRAD-M

King's College London

Phase NA Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡